A therosclerosis is an inflammatory progressive disease of the vascular wall. 1,2 Its sequelae, including myocardial infarction and ischemic stroke, are leading causes of mortality and morbidity in the industrialized countries. 3, 4 Atherogenesis is initiated by recruitment of monocytes as well as monocyte-derived macrophages to the vascular wall with chronic inflammation continuing throughout plaque development. 5-7 Migration of monocytes or macrophages during early Objective-Atherosclerosis, an inflammatory disease of arterial vessel walls, requires migration and matrix metalloproteinase (MMP)-9-dependent invasion of monocytes/macrophages into the vascular wall. MMP-9 expression is stimulated by transcription factor nuclear factor-κB, which is regulated by inhibitor κB (IκB) and thus IκB kinase. Regulators of nuclear factor-κB include serum-and glucocorticoid-inducible kinase 1 (SGK1). The present study explored involvement of SGK1 in vascular inflammation and atherogenesis. Approach and Results-Gene-targeted apolipoprotein E (ApoE)-deficient mice without (apoe −/− sgk1 +/+ ) or with (apoe −/− sgk1 −/− ) additional SGK1 knockout received 16-week cholesterol-rich diet. According to immunohistochemistry atherosclerotic lesions in aorta and carotid artery, vascular CD45 + leukocyte infiltration, Mac-3 + macrophage infiltration, vascular smooth muscle cell content, MMP-2, and MMP-9 positive areas in atherosclerotic tissue were significantly less in apoe −/− sgk1 −/− mice than in apoe −/− sgk1 +/+ mice. As determined by Boyden chamber, thioglycollate-induced peritonitis and air pouch model, migration of SGK1-deficient CD11b + F4/80 + macrophages was significantly diminished in vitro and in vivo. Zymographic MMP-2 and MMP-9 production, MMP-9 activity and invasion through matrigel in vitro were significantly less in sgk1 −/− than in sgk1 +/+ macrophages and in control plasmid-transfected or inactive K127N SGK1transfected than in constitutively active S422D SGK1-transfected THP-1 cells. Confocal microscopy revealed reduced macrophage number and macrophage MMP-9 content in plaques of apoe −/− sgk1 −/− mice. In THP-1 cells, MMP-inhibitor GM6001 (25 μmol/L) abrogated S422D SGK1-induced MMP-9 production and invasion. According to reverse transcription polymerase chain reaction, MMP-9 transcript levels were significantly reduced in sgk1 −/− macrophages and strongly upregulated in S422D SGK1-transfected THP-1 cells compared with control plasmid-transfected or K127N SGK1-transfected THP-1 cells. According to immunoblotting and confocal microscopy, phosphorylation of IκB kinase and inhibitor κB and nuclear translocation of p50 were significantly lower in sgk1 −/− macrophages than in sgk1 +/+ macrophages and significantly higher in S422D SGK1-transfected THP-1 cells than in control plasmid-transfected or K127N SGK1-transfected THP-1 cells. Treatment of S422D SGK1-transfected THP-1 cells with IκB kinase-inhibitor BMS-345541 (10 μmol/L) abolished S422D SGK1-induced increase of MMP-9 transcription and gelatinase activity. Conclusions-SGK1 plays a pivotal role in vascular inflammation during atherogenesis. SGK1 participates in the regulation of monocyte/macrophage migration and MMP-9 transcription via regulation of nuclear factor-κB. (Arterioscler Thromb Vasc Biol. 2015;35:547-557. The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/
stages of atherosclerosis is primarily driven by monocyte chemoattractant protein (MCP)-1. 6, 7 The number of monocytes/ macrophages infiltrating into the vessel wall correlates with the extent of inflammation. 2, 8, 9 This inflammatory process can ultimately lead to the development of complex atherosclerotic lesions that protrude into the arterial lumen. 4 During all stages of atherogenesis, monocytes and macrophages secrete proteolytic enzymes, which may influence plaque composition or stability. 10, 11 Migration of macrophages into atherosclerotic tissue as well as subsequent plaque remodeling and progression require the degradation of tissue matrix proteins by matrix metalloproteinases (MMPs) such as MMP-2 or MMP-9. [12] [13] [14] [15] Expression of the MMP-9 is regulated by the nuclear transcription factor nuclear factor (NF)-κB, 2, 16 which plays a major role in vascular inflammation underlying the development of atherosclerotic lesions. 17 But although MMP-9 mainly derives from monocytes/macrophages recruited to inflamed arterial vessel wall during atherogenesis, the key regulatory mechanisms of NF-κB-dependent regulation of MMP-9 expression in lesionassociated macrophages have not been identified yet. 9, 18 The proinflammatory transcription factor NF-κB is retained inactive in the cytoplasm through association with the inhibitor κB (IκB) protein. 19 On phosphorylation, IκB kinase (IKK) phosphorylates IκB thus initiating the ubiquitination and subsequent degradation of IκB followed by translocation of NF-κB into the nucleus with initiation of NF-κB-dependent gene expression. 2, 20 Atherogenesis requires multiple cell signaling mechanisms involving different protein kinases such as phosphoinositide-3 kinase (PI3K). 3 Signaling molecules regulated by PI3K signaling include the serum-and glucocorticoid-inducible kinase 1 (SGK1), a kinase belonging to the AGC family of serine/ threonine protein kinases. 21, 22 SGK1 is regulated by a variety of triggers, such as hyperglycemia, oxidative stress, or ischemia. 23 Excessive upregulation of SGK1 transcript levels has been shown to parallel several inflammatory diseases as glomerulonephritis, diabetes mellitus, or autoimmune encephalitis. [23] [24] [25] Moreover, SGK1 plays a critical role in inflammatory cytokine expression as well as in ventricular and vascular remodeling. 21, [26] [27] [28] Recently, SGK1 has been shown to foster coagulation and to play a crucial role in the development of acute arterial thrombosis by triggering platelet activation, and a gain-of-function SGK1 gene variant was identified to be associated with ischemic stroke. 21, 22, 29 Thereby, SGK1 is in part effective by upregulating NF-κB. 17, 18 There is growing evidence indicating that SGK1 is heavily expressed in macrophages and plays an important role in cellular migration. 28, 30 Although inflammatory infiltration of the vascular wall by immigrating monocytes and monocytederived macrophages is critical to the development of atherosclerosis and although SGK1 is considered a candidate gene fostering the development of atherosclerosis, 31 nothing is hitherto known about the influence of SGK1 in atherogenesis.
The present study explored whether SGK1 is causally involved in vascular inflammation and remodeling as well as development of atherosclerotic lesion formation and if so, to identify the potential underlying cellular mechanisms.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results
To study the functional role of SGK1 in atherogenesis, we used the apolipoprotein E (ApoE)-deficient mouse, a wellknown model of atherosclerosis. 32 To induce atherosclerosis, gene-targeted mice lacking ApoE (apoe −/− sgk1 +/+ ) or double knockout mice lacking both, ApoE and SGK1 (apoe −/− sgk1 −/− ) were fed a high-cholesterol diet for 16 weeks. Apoe −/− sgk1 +/+ and apoe −/− sgk1 −/− mice show comparable hematologic parameters and no significant differences in plasma cholesterol as well as triglyceride levels (Tables I and II in the online-only Data Supplement). To visualize atherosclerotic plaques, aortas were stained with oil red O. As illustrated in Figure 1 , the atherosclerotic lesions in the aortic tree from the ascending aorta to the iliac bifurcation were significantly blunted in apoe −/− sgk1 −/− mice as compared with apoe −/− sgk1 +/+ mice. Accordingly, the areas covered by atherosclerotic lesions in thoracic aortic arch (30.3% versus 42.0%; P=0.04), thoracic aorta (9.6% versus 23.6%; P<0.01), abdominal aorta (9.2% versus 19.2%; P<0.01), and carotid artery (10.6% versus 24.6%; P<0.01) were significantly smaller in apoe −/− sgk1 −/− mice than in apoe −/− sgk1 +/+ mice ( Figure 1 ). The differences in the area of atherosclerotic lesions were further observed using histology of the aortic sinus ( Figure 2 ). Again, the area covered by atherosclerotic lesions in the aortic sinus was significantly smaller in apoe −/− sgk1 −/− mice than in apoe −/− sgk1 +/+ mice (255 versus 439×10 3 μm 2 ; P<0.01). In addition, the lipid content of atherosclerotic lesions was significantly lower in apoe −/− sgk1 −/− mice than in apoe −/− sgk1 +/+ mice ( Figure 1 in the online-only Data Supplement).
Because infiltration of inflammatory cells, such as monocytes and monocyte-derived macrophages, into the arterial vessel wall is a crucial step in atherogenesis, plaque area and plaque infiltration by inflammatory cells in cross sections of the aortic arch were analyzed by hematoxylin-eosin staining and immunohistochemistry. As shown in Figure 3 , infiltration of inflammatory cells into the aortic wall was significantly less in apoe −/− sgk1 −/− mice than in apoe −/− sgk1 +/+ mice. Furthermore, immunohistochemistry revealed significantly lower abundance of CD45 + ( (Figure 3 ). These results suggest that a defect in monocyte/ macrophage as well as vascular smooth muscle cell recruitment in SGK1-deficient mice apparently underlies the reduced inflammatory infiltration of the arterial vessel wall and the diminished macrophage content of atherosclerotic lesions of apoe −/− sgk1 −/− mice.
To address the role of SGK1 in migration of monocytes and monocytes-derived macrophages to the site of inflammation, we performed a series of in vitro experiments using Boyden chambers toward the inflammatory chemoattractant MCP-1 (10 ng/mL). Addition of MCP-1 increased the number of sgk1 +/+ macrophages but not of sgk1 −/− macrophages. As shown in Figure 4A and 4C, migratory activity toward a MCP-1 source was significantly less in sgk1 −/− monocytes/ macrophages than in sgk1 +/+ monocytes/macrophages (18 versus 72 macrophages/high power field; P<0.01). An analysis of Ly-6C hi and Ly-6C lo subset number and ratio of sgk1 −/− or sgk1 +/+ monocytes revealed a significantly lower number of Ly-6C hi monocytes and a significantly higher number of Ly-6C lo monocytes in SGK1-deficient mice ( Figure II Additional experiments were performed with the human monocytic leukemia cell line THP-1. Before the experiments THP-1 cells were transfected with control plasmid, the constitutively active mutant S422D SGK1 or with the inactive mutant K127N SGK1. As illustrated in Figure 4B , both, in the absence and presence of MCP-1, the chemotactic index of S422D SGK1transfected THP-1 cells was significantly higher than the chemotactic index of THP-1 cells transfected with control plasmid (−MCP1: 1.95 versus 1.0; P<0.01 and +MCP1: 5.04 versus 1.89; P<0.01) or K127N SGK1 (−MCP1: 1.95 versus 1.06; P<0.05 and +MCP1: 5.04 versus 2.35; P<0.05).
To examine SGK1-dependent macrophage recruitment into inflamed tissues in vivo, we used the thioglycollate-induced peritonitis and air pouch model as the classical models of macrophage-driven inflammation. 33 To this end 4% thioglycollate was injected into the peritoneal cavity of sgk1 +/+ and sgk1 −/− mice. The number of CD11b + F4/80 + macrophages in the peritoneal lavage 0, 48, and 96 hours after thioglycollate injection was analyzed by flow cytometry. As illustrated in Figure 4D , both, 48 hours (678 versus 1280×10 3 ; P<0.01) and 96 hours (1910 versus 3771×10 3 ; P<0.01) after thioglycollate injection, the abundance of CD11b + F4/80 + macrophages in the peritoneal lavage was significantly lower in mice lacking SGK1 (sgk1 −/− ) than in their wild-type littermates (sgk1 +/+ ). The diminished response in macrophage recruitment into the peritoneum in response to thioglycollate-induced peritonitis was not biased by a diminished source of leukocytes in mice lacking SGK1 because levels of blood leukocytes and monocytes were similar in sgk1 −/− and sgk1 +/+ mice ( Table I in the air pouch model. The number of CD11b + F4/80 + macrophages in the lavage 24 hours after injection of tumor necrosis factor (TNF)-α (500 ng in 200-μL PBS) was analyzed by flow cytometry. As illustrated in Figure 4E , after 24 hours, the abundance of CD11b + F4/80 + macrophages in the lavage was significantly lower in sgk1 −/− mice than in sgk1 +/+ mice (−TNF-α: 10 828 versus 14 861; P=0.26 and +TNF-α: 44 910 versus 77 443; P<0.01).
As expression of MMP-9 in atherosclerotic plaques was less in apoe −/− sgk1 −/− mice than in apoe −/− sgk1 +/+ mice ( Figure 3 ) and as MMP-9 is critically important for matrix degradation, a prerequisite for invasion, we examined SGK1-dependent regulation of monocytes/macrophages MMP-9 production and invasion. To this end, macrophages were cultivated from sgk1 +/+ mice and sgk1 −/− mice and tested for invasion capacity in a matrigel invasion assay ( Figure 5A and 5C). As a result, the number of sgk1 +/+ macrophages migrating through the matrigel-coated transwell toward a source of MCP-1 was significantly higher than the number of migrated sgk1 −/− macrophages (59.7 versus 23.3 macrophages/high power field; P<0.01). As illustrated in Figure 5B , after PMA (phorbol 12-myristate 13-acetate) treatment, invasion index through matrigel was significantly higher in THP-1 cells transfected with S422D SGK1 than in THP-1 cells transfected with control plasmid (2.73 versus 1.0; P<0.01) or inactive K127N SGK1 (2.73 versus 1.16; P<0.05). As illustrated in Figure 5A to 5C, addition of MMP-inhibitor GM6001 (25 μmol/L) significantly decreased the migratory activity of S422D SGK1-transfected THP-1 cells through matrigel and dissipated the differences in invasion activity between sgk1 +/+ and sgk1 −/− macrophages as well as between S422D SGK1transfected THP-1 cells and control-transfected THP-1 cells or K127N SGK1-transfected THP-1 cells. These results indicate that regulation of MMP production is crucial for SGK1-dependent modulation of monocytes/macrophages invasion.
To test the hypothesis that SGK1 directly influences monocytes/macrophages invasive ability and MMP-9 production, we performed gelatin zymography, confocal microscopy, and reverse transcription polymerase chain reaction experiments. As illustrated in Figure 6C , the number of macrophages in atherosclerotic lesions was significantly reduced in apoe −/− sgk1 −/− mice and expression levels of MMP-9 were significantly diminished in sgk1 −/− macrophages compared with sgk1 +/+ macrophages. Although production of pro-MMP-2 as well as pro-MMP-9 and consecutively production of functionally active MMP-2 and MMP-9 increased in a time-dependent manner in sgk1 +/+ macrophages, sgk1 −/− macrophages displayed an impaired MMP production after 0, 4, 8, 16, and 24 hours ( Figure 6A and 6B; Figure III in the online-only Data Supplement). As displayed in Figure 6D , MMP-9 amount was significantly lower in sgk1 −/− macrophages (15.61 versus 26.08 pg/mL; P<0.01) and stimulation-triggered upregulation of MMP-9 abundance significantly blunted in SGK1-deficient macrophages (27.08 versus 60.13 pg/mL; P<0.01) as compared with sgk1 +/+ macrophages. Moreover, as shown in Figure 6E , transfection of THP-1 cells with the constitutively active mutant S422D SGK1 significantly increased MMP-9 (and MMP-2; Figure IV in the online-only Data Supplement) production compared with THP-1 cells transfected with control plasmid (MMP-9: 185% versus 100%; P<0.01 and MMP-2: 212% versus 100%; P<0.01) or the inactive mutant K127N SGK1 (MMP-9: 185% versus 122%; P<0.05 and MMP-2: 212% versus 112%; P<0.01). According to MMP-9 activity assay ( Figure 6F ), MMP-9 activity was significantly lower in sgk1 −/− macrophages compared with sgk1 +/+ macrophages (0.63 versus 1.0; P<0.01). Moreover, stimulation-induced increase of MMP-9 activity was significantly impaired in sgk1 −/− macrophages compared with sgk1 +/+ macrophages (1.28 versus 3.39; P<0.05).
According to reverse transcription polymerase chain reaction, mRNA levels of MMP-9 were significantly decreased in sgk1 −/− macrophages compared with sgk1 +/+ macrophages (50% versus 100%; P<0.05; Figure 7A ). Moreover, MMP-9 transcript levels were significantly upregulated in S422D SGK1transfected THP-1 cells compared with THP1 cells transfected with control plasmid (261% versus 100%; P<0.05) or K127N SGK1 (261% versus 98%; P<0.01; Figure 7B ). In a further series of experiments, we examined the mechanisms underlying SGK1 sensitive MMP-9 transcription. MMP-9 production is known to be regulated by the transcription factor NF-κB, which is regulated by the inhibitor protein IκB. 2, 16 Phosphorylation of IκB by the IκB kinase IKKα/β is followed by degradation of IκB with subsequent translocation of NF-κB into the nucleus. 20 IKKα/β is itself activated by phosphorylation. Accordingly, phosphorylation of IKKα/β as well as IκB has been determined in macrophages and THP-1 cells. As illustrated in Figure 7C , IKKα/β phosphorylation was significantly less pronounced in sgk1 −/− macrophages than in sgk1 +/+ macrophages (53% versus 100%; P<0.01). Moreover, as shown in Figure 7E , IKKα/β phosphorylation was significantly more pronounced in S422D SGK1-transfected THP-1 cells than in control-transfected THP-1 cells (199% versus 100%; P<0.05) or in K127N SGK1-transfected THP-1 cells (199% versus 96%; P<0.01). Similar observations were made in Western blots of IκB phosphorylation. According to Figure 7D , the abundance of phosphorylated IκB was significantly less pronounced in sgk1 −/− macrophages than in sgk1 +/+ macrophages (58% versus 100%; P<0.01). Moreover, as illustrated in Figure 7F , the abundance of phosphorylated IκB was significantly higher in S422D SGK1-transfected THP-1 cells than in control-transfected THP-1 cells (159% versus 100%; P<0.05) or in K127N SGK1-transfected THP-1 cells (159% versus 91%; P<0.01). As shown by confocal microcopy nuclear translocation of the NF-κB subunit p50 in macrophages of atherosclerotic lesions was less pronounced in apoe −/− sgk1 −/− mice than in apoe −/− sgk1 +/+ mice ( Figure 7I ). For further examination of SGK1-dependent regulation of NF-κB-driven MMP-9 transcription, the highly selective IKK-inhibitor BMS-345541 (10 μmol/L) was used, which has >10-fold selectivity for IKKβ than for IKKα. 22 According to Figure 7G and 7H, treatment of S422D SGK1-transfected THP-1 cells with the IKK-inhibitor BMS-345541 (10 μmol/L) completely abolished SGK1-induced increase of MMP-9 mRNA levels (69% versus 208%; P<0.01) and gelatinase activity (106% versus 172%; P<0.01) confirming NF-κB dependence of SGK1 sensitive transcriptional regulation of MMP-9 in monocytes/macrophages.
Discussion
The present study reveals a critical role of the SGK1 in vascular inflammation and the development of atherosclerotic lesions. Moreover, underlying pathophysiological mechanisms by which SGK1 may promote atherogenesis could be characterized.
The major findings of the present study are (1) SGK1 deficiency decreases the in vivo atherosclerotic lesion burden. (2) SGK1 is critically important for monocyte and macrophage recruitment during vascular inflammation and atherogenesis in vitro and in vivo. (3) SGK1 is critically important for NF-κB-dependent regulation of MMP-9 transcript levels and MMP-9-triggered matrix degradation. Because atherosclerosis is an inflammatory disease driven by over-recruitment of monocytes and monocyte-derived macrophages into an arterial lesion, macrophages are decisive for chronic vascular inflammation, which underlies the pathogenesis of atherosclerosis. 34, 35 Beside monocyte recruitment, accumulation of monocytederived macrophages in atherosclerotic plaques depends on the balance between local proliferation and apoptosis as well as egress and clearance of apoptotic macrophages. 36, 37 Although monocyte migration into plaques seems to be a major pathophysiological process in atherogenesis, 36 blunted accumulation of inflammatory cells and reduced plaque burden in sgk1 −/− mice could be influenced by further SGK1dependent mechanisms involving modified migratory egress or apoptosis of macrophages.
We hypothesized that SGK1 may play an important role in several stages of atherogenesis because of triggering vascular inflammation by promoting monocyte/macrophage recruitment, migration, and invasion to the arterial vessel wall. The serine-threonine kinase SGK1 is one of the major downstream effectors of PI3K-dependent signaling in response to growth factors or oxidative stress. 22, 28 Numerous previous studies have established the importance of PI3K-dependent signaling in responses of monocytes and macrophages to atherogenic mediators promoting atherosclerosis. 3 Along those lines deletion of PI3K p110γ significantly diminished macrophages migration/accumulation in the peritonitis model and attenuated murine atherogenesis. 3, 38 In those earlier studies the PI3K-dependent signaling and respective functions in macrophage recruitment and atherogenesis have been incompletely defined. Particularly, the role of SGK1 remained unknown. There is growing evidence that oxidative stress and metabolic disorders (eg, diabetes mellitus or hyperglycemia) induce a hyperchemotactic and proatherogenic monocyte phenotype accelerating atherosclerotic lesion formation by increased macrophage recruitment. 7, 39, 40 Beside a wide variety of hormones, mediators, and conditions including adrenal steroids, insulin, growth factors, cell shrinkage, and energy depletion, expression and activity of SGK1 and its downstream target NF-κB are particularly upregulated by diabetic hyperglycemia, glucose-induced advanced glycation end-products, and oxidative stress. 23, 41 SGK1 has already been discussed to play an important role in inflammatory processes because SGK1deficient mice were found to be resistant to experimental autoimmune encephalomyelitis. 25 The present study reveals the importance of SGK1 for monocyte as well as monocyte-derived macrophage migration in response to MCP-1, which is strongly expressed in atherosclerotic tissue 42 and mainly triggers chemotaxis of monocytes and macrophages to inflammatory vascular lesions. 43, 44 Impaired recruitment of sgk1 −/− monocytes could in part result from a significantly lower ratio of inflammatory Ly-6C hi to less inflammatory Ly-6C lo monocytes in SGK1-deficient mice. Recent studies revealed that Ly-6C hi monocytes are particularly adhesive to activated endothelium, thus triggering vascular infiltrations and generating lesional macrophages. 45 Nevertheless, CX3CL1-induced in vitro invasion ( Figure V in the online-only Data Supplement) as well as TNF-α-triggered in vivo migration (air pouch model, Figure 4E ) were also significantly impaired in sgk1-deficient macrophages. These results are in line with recent findings disclosing the critical participation of SGK1 in the regulation of migration in other cell types. 30 The present observations further shed some light on the molecular mechanism involved in SGK1-sensitive vascular recruitment of monocytes and monocyte-derived macrophages. The enhanced invasion of SGK1-expressing monocytes and macrophages is at least in part because of enhanced expression of MMP-2 and MMP-9. Synthesis of matrix-degrading metalloproteinase MMP-2 and MMP-9 by monocytes and macrophages plays an essential role in their migration through tissue. 46 Previous studies have shown that macrophage migration through the peritoneal membrane into the peritoneal cavity after thioglycollate-induced peritonitis or across an artificial matrigel barrier (invasion) critically requires secretion of MMP-9 from monocytes or monocytederived macrophages. 13 MMP-9 gene variants have previously been associated with coronary heart disease, myocardial infarction, and stroke, 47, 48 an observation pointing to the relevance of altered MMP-9 expression. Atherosclerotic plaque formation in apoe −/− sgk1 −/− mice is similar to the phenotype found in apoe −/− mmp9 −/− because loss of MMP-9 reduced atherosclerotic burden throughout the aorta and impaired macrophage infiltration and collagen deposition. 15 Nevertheless, although reduced MMP-9 expression and activity in SGK1deficient macrophages are expected to impair macrophage invasion into atherosclerotic plaques of sgk1 −/− mice, results of the in vitro matrigel invasion model cannot be translated without reservations into the complex mechanisms involved in macrophage invasion in vivo.
Like MMP-2, MMP-9 is required for vascular smooth muscle cell migration. 49 Therefore, we speculate that reduced MMP-2 and MMP-9 content in apoe −/− sgk1 −/− mice resulted in reduced vascular smooth muscle cell migration in these mice. Besides contributing to plaque progression and instability, MMP-9 probably has beneficial effects on adaptive plaque remodeling processes 50 because MMP-9 is necessary for vascular smooth muscle cell-driven fibrous cap formation promoting plaque stability. 51, 52 Moreover, the results of this study reveal a putative mechanism in the SGK1-dependent upregulation of MMP-9 expression. Monocyte as well as monocyte-derived macrophage MMP-9 is tightly regulated at the transcriptional level by the transcription factor NF-κB 2, 16 and rapidly increases in processes involved in vascular inflammation and atherogenesis. 11, 53 However, the precise factors that stimulate MMP elaboration in lesion-associated macrophages have not been well characterized to date. 9 NF-κB is active in lesion-prone regions and NF-κBregulated inflammatory responses play major roles in atherosclerotic lesion initiation and progression of atherogenesis. 4, 17 Distinct pathways of NF-κB activation merge at the level of IκB kinase complex activation. 17 Phosphorylation of IKK is essential for inflammation triggering macrophage chemotaxis. 19 As already shown in other cell types, 21, 22 SGK1 effectively regulates transcription by upregulating NF-κB activity through phosphorylation and activation of IKKα/β. Thus, SGK1 enhances the ability of IKKα/β to phosphorylate endogenous IκBα. 54 Besides MMP-9 SGK1 modulates the transcription of further proinflammatory molecules in monocyte-derived macrophages including TNF-α and MCP-1 in a NF-κB-dependent manner ( Figure VI in the online-only Data Supplement) supporting the hypothesis that SGK1 is decisively involved in promoting vascular inflammation and atherogenesis.
Atheroprogression is further fostered by platelets, which initiate and maintain vascular inflammation by triggering leukocyte recruitment to the vessel wall. 5 Thus, the reduced inflammatory infiltration of the vessel wall could in part result from defective platelet function in SGK1-deficient mice. 22 In conclusion, our data suggest that SGK1 contributes to vascular inflammation and formation of atherosclerotic lesions. SGK1 regulates the migration of monocytes/ macrophages and presumably contributes to the regulation of monocyte/macrophage recruitment and invasion during atherogenesis. In view of the present observations, it is tempting to speculate that enhanced SGK1-mediated NF-κB activation in monocytes/macrophages with NF-κB-dependent upregulation of MMP-9 transcript level and production triggering macrophage invasion into and inflammation of the arterial vessel wall contribute to inflammation within atherosclerotic plaques and subsequent progression of atherogenesis. Therefore, SGK1 may present a potential therapeutic target in the prevention of vascular inflammation and development of atherosclerotic disease. 
